October 01, 2016 4:53 AM ET

Pharmaceuticals

Company Overview of Inverseon, Inc.

Company Overview

As of August 30, 2012, Inverseon, Inc. was acquired by Invion Limited. Invion Limited, a clinical-stage drug development company, focuses on the treatments for anti-inflammatory diseases. It focuses on the development of treatments for asthma, chronic bronchitis, and lupus.

1701 Jackson Street

Suite 102

San Francisco, CA 94109

United States

Founded in 2004

Phone:

415-440-7400

Fax:

415-440-7402

Key Executives for Inverseon, Inc.

Inverseon, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Inverseon, Inc., please visit www.inverseon.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.